List view / Grid view
7 July 2015 | By Victoria White
Allergan is to acquire exclusive worldwide rights to Merck's CGRP receptor antagonists, which are being developed for the treatment of migraine...
6 July 2015 | By Victoria White
Allergan is to acquire Oculeve. The acquisition will add novel, complementary dry eye development programmes to Allergan's portfolio...
18 November 2014 | By Actavis
Joshua Owide, GlobalData’s Director of Healthcare Industry Dynamics, says: “Actavis has agreed to purchase Allergan for around $66 billion, in a deal which draws to an end Valeant’s lengthy wrangle to acquire the Botox manufacturer..."
9 January 2014 | By Allergan
New aesthetic indication for market-leading neuromodulator which can now help improve appearance of lines around the eyes, as well as treating glabellar frown lines...
23 October 2013 | By Chandler Chicco Agency
Positive opinion paves the way for a second aesthetic indication for VISTABEL® in 29 European countries...
